FTRE Q3 2023 Earnings — Fortrea Holdings Inc. Revenue & Financial Results | Market Cap Arena

FTREFortrea Holdings Inc.

$851M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$714M-6.4% YoY

Gross Profit

$150M21.0% margin

Operating Income

$10M1.4% margin

Net Income

-$14M-2.0% margin

EPS (Diluted)

$-0.15

QoQ Revenue Growth

-1.6%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

-$3M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$4.3B

Total Liabilities

$2.6B

Stockholders' Equity

$1.7B

Cash & Equivalents

$108M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$714M	$762M	-6.4%
Gross Profit	$150M	$168M	-10.4%
Operating Income	$10M	$69M	-85.1%
Net Income	-$14M	$61M	-123.1%

Revenue Segments

Clinical Services Segment

$712M100%

Geographic Segments

North America

$412M53%

Europe

$204M26%

Other Geographical Areas

$160M21%